Protective effects of Crocin on hepatic steatosis, oxidative stress, and lipid profile in an animal model of non-alcoholic fatty liver disease
PLOS One · 2026
DOI: 10.1371/journal.pone.0357768 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Hossain Rezayee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran. Hauptthemen laut MEDLINE: Carotenoids, Oxidative Stress, Non-alcoholic Fatty Liver Disease, Lipid Metabolism. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Torbat Heydariyeh University of Medical Sciences.
Abstract (Originalsprache)
Objective
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disorder worldwide. This study aims to investigate the effects of crocin on lipid profile, hepatic lipid accumulation, and antioxidant status in a rat model of non-alcoholic fatty liver induced by a high-fat diet. Materials and methods Forty-two male Wistar rats were divided into six groups, each containing seven rats. Fatty liver was induced by feeding a high-fat diet for eight weeks. Subsequently, the treatment groups received intraperitoneal crocin for four weeks. The groups were then evaluated for changes in serum lipid profiles, liver function enzymes in serum, oxidative stress biomarkers and histopathological alterations in liver tissue.
Results
High-fat diet feeding resulted in significant hepatic lipid accumulation, elevated serum aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase levels, increased hepatic malondialdehyde and nitrite concentrations, and impaired antioxidant enzyme activities. Histological analysis demonstrated hepatocellular steatosis, inflammatory infiltration, and hepatic structural alterations. Crocin treatment significantly attenuated lipid accumulation, normalized serum liver enzyme levels, reduced oxidative stress markers, and enhanced antioxidant enzyme activities. Histopathological evaluation further confirmed marked improvement in liver tissue morphology.
Conclusion
The results of the present study demonstrate that Crocin exerts protective effects against NAFLD, highlighting its potential as a therapeutic agent for diet-induced fatty liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
- Department of Paracilinic, Faculty of Medicine, Khatam Al-Nabieen University, Kabul, Afghanistan.
- Department of Clinical Biochemistry, School of Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
- Research Center of Advanced Technologies in Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
- Departments of Physiology, School of Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
- Neuroscience Research Center, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
ORCID-Profile: Davod Ilbeigi
Förderung
- Torbat Heydariyeh University of Medical Sciences
Zitieren
APA
Rezayee, H., Fahmidehkar, M. A., Beheshti, F., Ghoryani, M., Yousefpoor, Y., Hossaini, D., & Ilbeigi, D. (2026). Protective effects of Crocin on hepatic steatosis, oxidative stress, and lipid profile in an animal model of non-alcoholic fatty liver disease. PLOS One. https://doi.org/10.1371/journal.pone.0357768
Vancouver
Rezayee H, Fahmidehkar MA, Beheshti F, Ghoryani M, Yousefpoor Y, Hossaini D, et al. Protective effects of Crocin on hepatic steatosis, oxidative stress, and lipid profile in an animal model of non-alcoholic fatty liver disease. PLOS One. 2026. doi:10.1371/journal.pone.0357768
BibTeX
@article{Rezayee2026,
author = {Rezayee, Hossain and Fahmidehkar, Mohammad Ali and Beheshti, Farimah and Ghoryani, Mohsen and Yousefpoor, Yaser and Hossaini, Dawood and Ilbeigi, Davod},
title = {Protective effects of Crocin on hepatic steatosis, oxidative stress, and lipid profile in an animal model of non-alcoholic fatty liver disease},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0357768}
}
EUVIMED